𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Vaccination against hepatitis a in patients with chronic liver disease

✍ Scribed by Irphan Gaslightwala; Edmund J. Bini

Book ID
107540425
Publisher
Current Science Inc.
Year
2006
Tongue
English
Weight
89 KB
Volume
5
Category
Article
ISSN
1540-3416

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Hepatitis B vaccination of patients with
Hepatitis B vaccination of patients with chronic liver disease
✍ Keeffe, Emmet B. ;Krause, David S. πŸ“‚ Article πŸ“… 1998 πŸ› Wiley (John Wiley & Sons) 🌐 English βš– 29 KB πŸ‘ 1 views

De novo hepatitis B infection after liver transplantation, in spite of its low prevalence as found by Fabia et al, 1 is of major concern, especially for infected patients and their families. More follow-up time is needed to assess the real impact in morbidity, mortality, and economic costs. Althoug

Safety and immunogenicity of hepatitis A
Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease
✍ Emmet B. Keeffe; Sten Iwarson; Brian J. McMahon; Karen L. Lindsay; Raymond S. Ko πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 74 KB πŸ‘ 2 views

Acute hepatitis A superimposed on chronic liver disease (CLD) has been associated with severe or fulminant hepatitis. An open, multicenter study was performed to compare the safety and immunogenicity of an inactivated hepatitis A vaccine in patients with CLD with that in healthy subjects. A secondar

Safety and immunogenicity of inactivated
Safety and immunogenicity of inactivated hepatitis A vaccine in patients with chronic liver disease
✍ Lee, Shou-Dong; Chan, Cho-Yu; Yu, May-Ing; Wang, Yuan-Jen; Chang, Full-Young; Lo πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 298 KB πŸ‘ 2 views

The safety and immunogenicity of inactivated hepatitis A vaccine was evaluated in patients with chronic liver disease. Sixty hepatitis A virus antibody (anti-HAV) seronegative patients with chronic liver disease (56 chronic hepatitis B and four chronic hepatitis C) and from 17 to 47 years of age rec